Bottom line
Is REVS a good fund? The bottom line
REVS is an actively managed large value ETF from Columbia Threadneedle.
It charges 0.19% — about $19 a year on every $10,000 invested, cheaper than 93% of large value funds we track.
It returned +16.6% over one year, +13.2% a year over five years (as of Dec 31, 2025, per its prospectus).
With $334 million in net assets and 307 holdings, its largest position is Apple Inc (8.0%) and the top 10 make up 32.5% of the portfolio.
What stands out
- Low cost: cheaper than 93% of large value peers
- 5-year return beat 84% of category peers
- Broadly diversified (307 holdings)
Updated Nov 19, 2026
What REVS invests in
Columbia Research Enhanced Value ETF (the Fund) seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage Research Enhanced U.S. Value Index (the Index).
The Fund is an exchange-traded fund (ETF) that seeks to replicate the performance of the Index. The Fund invests at least 80% of its assets in the securities of the Index. The Index reflects a rules-based strategic beta approach to investing in the companies that comprise the Russell 1000 Value Index, designed to achieve stronger total return when compared to the Russell 1000 Value Index, which is a broad measure of the performance of U.S. large- and mid-cap value companies. The Index, like the Russell 1000 Value Index, and therefore the Fund, typically holds only common stocks. The Index was developed and is sponsored and administered by the Funds investment adviser, Columbia Management Investment Advisers, LLC (Columbia Management or the Investment Manager). The Index is calculated and maintained by FTSE Russell. The Index is comprised of a subset of the companies within the Russell…
From the fund's prospectus (filed Feb 26, 2026).
REVS performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| REVS | +16.6% | +13.2% | — |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What REVS costs
On a $10,000 investment, REVS's 0.19% expense ratio costs about $19 a year. The prospectus estimates $254 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
REVS top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Apple Inc | 8.00% |
| 2 | Microsoft Corp | 6.81% |
| 3 | Bank of America Corp | 3.85% |
| 4 | Chevron Corp | 2.73% |
| 5 | Altria Group Inc | 2.22% |
| 6 | Citigroup Inc | 1.90% |
| 7 | Meta Platforms Inc | 1.79% |
| 8 | Bristol-Myers Squibb Co | 1.79% |
| 9 | TJX Cos Inc/The | 1.73% |
| 10 | Cisco Systems Inc | 1.70% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 32.5% of the fund. See all top 25 holdings and asset mix →